重大突破！常州二院放疗科牵头国家级重点项目，破解放疗“卡脖子”难题

Core Viewpoint - The Ministry of Science and Technology has announced the approval of a key project under the 2025 National Key R&D Program focused on "Diagnostic Equipment and Biomedical Materials," led by Professor Ni Xinye from the Third Affiliated Hospital of Nanjing Medical University, addressing critical challenges in real-time dose verification in radiation therapy [1][2]. Group 1: Project Details - The approved project is the first National Key R&D Program project in Jiangsu's radiation therapy sector, with a project leader from the Changzhou health system [1]. - The project aims to tackle the "bottleneck" issue of in-vivo dose verification in radiation therapy by integrating resources from universities, hospitals, and leading enterprises, establishing a collaborative innovation mechanism [1]. Group 2: Impact and Significance - The research outcomes are expected to provide crucial support for clinical translation and industrial upgrading in cutting-edge fields like real-time adaptive radiotherapy, contributing significantly to the implementation of the "Healthy China" strategy [1]. - The project will enhance the precision and safety of treatment for radiation therapy patients, facilitating a transition in China's radiation therapy from "planned precision" to "execution precision" [1].